![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NUP210 | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NUP210 mRNA | CTD | PMID:24763279 | NUP210 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUP210 mRNA | CTD | PMID:22206623 | NUP210 | Human | 1,3-dinitrobenzene | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in increased expression of NUP210 mRNA | CTD | PMID:21983209 | NUP210 | Human | 17beta-estradiol | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Estradiol results in decreased expression of NUP210 mRNA | CTD | PMID:26879975 | NUP210 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NUP210 mRNA | CTD | PMID:31614463 | NUP210 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of NUP210 mRNA | CTD | PMID:30165855 | NUP210 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Nup210 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | NUP210 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NUP210 mRNA | CTD | PMID:34747641 | NUP210 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NUP210 mRNA | CTD | PMID:33387578 | NUP210 | Human | 2,6-dinitrotoluene | affects expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of NUP210 mRNA | CTD | PMID:21346803 | NUP210 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of NUP210 protein | CTD | PMID:34915118 | NUP210 | Human | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of NUP210 mRNA | CTD | PMID:18648102 | NUP210 | Human | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of NUP210 gene | CTD | PMID:31601247 | NUP210 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of NUP210 mRNA | CTD | PMID:21346803 | NUP210 | Human | 4-hydroxynon-2-enal | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of NUP210 mRNA | CTD | PMID:19191707 | NUP210 | Human | acetamide | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of NUP210 mRNA | CTD | PMID:31881176 | NUP210 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NUP210 mRNA | CTD | PMID:32763439 | NUP210 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NUP210 gene | CTD | PMID:27153756 | NUP210 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of NUP210 intron | CTD | PMID:30157460 | NUP210 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of NUP210 intron | CTD | PMID:30157460 | NUP210 | Human | aminoglutethimide | decreases expression | EXP | | 6480464 | Aminoglutethimide results in decreased expression of NUP210 protein | CTD | PMID:26102013 | NUP210 | Human | ammonium chloride | affects expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of NUP210 mRNA | CTD | PMID:16483693 | NUP210 | Human | amphetamine | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of NUP210 mRNA | CTD | PMID:30779732 | NUP210 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of NUP210 mRNA | CTD | PMID:24449571 | NUP210 | Human | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of NUP210 mRNA | CTD | PMID:18414638 | NUP210 | Human | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of NUP210 mRNA | CTD | PMID:18414638 | NUP210 | Human | arsenite(3-) | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | arsenite results in increased expression of NUP210 protein | CTD | PMID:37955338 | NUP210 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of NUP210 mRNA | CTD | PMID:20064835 | NUP210 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NUP210 promoter | CTD | PMID:27901495 | NUP210 | Human | benzo[a]pyrene | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of NUP210 mRNA | CTD | PMID:19770486 and PMID:21569818 | NUP210 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | NUP210 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NUP210 exon | CTD | PMID:30157460 | NUP210 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of NUP210 mRNA | CTD | PMID:34319233 | NUP210 | Human | bisphenol A | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NUP210 mRNA | CTD | PMID:25181051 | NUP210 | Human | bisphenol A | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NUP210 mRNA | CTD | PMID:33221593 | NUP210 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of NUP210 mRNA | CTD | PMID:30903817 | NUP210 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of NUP210 mRNA | CTD | PMID:26079696 | NUP210 | Human | Butylbenzyl phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | cadmium dichloride | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of NUP210 mRNA | CTD | PMID:19010381 | NUP210 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NUP210 mRNA | CTD | PMID:38382870 | NUP210 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of NUP210 protein | CTD | PMID:35688186 | NUP210 | Human | carbon nanotube | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | NUP210 | Human | carbon nanotube | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of NUP210 mRNA | CTD | PMID:25620056 | NUP210 | Human | chlorpyrifos | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NUP210 mRNA | CTD | PMID:37019170 | NUP210 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NUP210 mRNA | CTD | PMID:38479592 | NUP210 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NUP210 mRNA | CTD | PMID:27594783 | NUP210 | Human | clofibric acid | multiple interactions | ISO | Nup210 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NUP210 mRNA | CTD | PMID:17602206 | NUP210 | Human | copper(II) chloride | decreases expression | EXP | | 6480464 | cupric chloride results in decreased expression of NUP210 mRNA | CTD | PMID:38568856 | NUP210 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of NUP210 mRNA | CTD | PMID:19549813 | NUP210 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | NUP210 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of NUP210 mRNA | CTD | PMID:19167446 | NUP210 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NUP210 mRNA | CTD | PMID:25562108 | NUP210 | Human | dexamethasone | increases expression | ISO | Nup210 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of NUP210 mRNA | CTD | PMID:22733784 | NUP210 | Human | dibutyl phthalate | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of NUP210 mRNA | CTD | PMID:17361019 and PMID:21266533 | NUP210 | Human | dibutyl phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of NUP210 mRNA | CTD | PMID:28302478 | NUP210 | Human | diethyl phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | diisobutyl phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | diisononyl phthalate | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA | CTD | PMID:39150890 | NUP210 | Human | dioxygen | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP210 mRNA | CTD | PMID:30529165 | NUP210 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | NUP210 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA | CTD | PMID:19167446 | NUP210 | Human | fenthion | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Fenthion results in decreased expression of NUP210 mRNA | CTD | PMID:34813904 | NUP210 | Human | fipronil | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of NUP210 mRNA | CTD | PMID:23962444 | NUP210 | Human | folic acid | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUP210 mRNA | CTD | PMID:22206623 | NUP210 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of NUP210 protein | CTD | PMID:37730182 | NUP210 | Human | furan | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | furan results in increased expression of NUP210 mRNA | CTD | PMID:25539665 | NUP210 | Human | gentamycin | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of NUP210 mRNA | CTD | PMID:22061828 | NUP210 | Human | gold atom | multiple interactions | EXP | | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA | CTD | PMID:28433809 | NUP210 | Human | gold(0) | multiple interactions | EXP | | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA | CTD | PMID:28433809 | NUP210 | Human | indinavir | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA | CTD | PMID:16931933 | NUP210 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of NUP210 protein | CTD | PMID:32959892 | NUP210 | Human | lamivudine | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA more ... | CTD | PMID:16931933 | NUP210 | Human | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of NUP210 mRNA | CTD | PMID:38568856 | NUP210 | Human | manganese(II) chloride | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of NUP210 mRNA | CTD | PMID:28801915 | NUP210 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NUP210 exon | CTD | PMID:30157460 | NUP210 | Human | methidathion | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | methidathion results in decreased expression of NUP210 mRNA | CTD | PMID:34813904 | NUP210 | Human | methoxychlor | affects methylation | ISO | Nup210 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of NUP210 gene | CTD | PMID:35440735 | NUP210 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of NUP210 mRNA | CTD | PMID:28001369 | NUP210 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NUP210 mRNA | CTD | PMID:28801915 | NUP210 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Nup210 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NUP210 mRNA | CTD | PMID:17602206 | NUP210 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of NUP210 mRNA | CTD | PMID:24768652 and PMID:25583101 | NUP210 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of NUP210 mRNA | CTD | PMID:22714537 | NUP210 | Human | oxaliplatin | multiple interactions | ISO | Nup210 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NUP210 mRNA | CTD | PMID:25729387 | NUP210 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NUP210 mRNA | CTD | PMID:22230336 | NUP210 | Human | paracetamol | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of NUP210 mRNA | CTD | PMID:33387578 | NUP210 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of NUP210 mRNA | CTD | PMID:26272509 | NUP210 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA | CTD | PMID:27188386 | NUP210 | Human | pirinixic acid | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NUP210 mRNA | CTD | PMID:17426115 | NUP210 | Human | pirinixic acid | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of NUP210 mRNA | CTD | PMID:19162173 and PMID:21318169 | NUP210 | Human | pirinixic acid | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUP210 mRNA | CTD | PMID:19710929 | NUP210 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of NUP210 mRNA | CTD | PMID:22714537 | NUP210 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of NUP210 mRNA | CTD | PMID:19162173 and PMID:21318169 | NUP210 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of NUP210 mRNA | CTD | PMID:21632981 | NUP210 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of NUP210 mRNA | CTD | PMID:19167446 | NUP210 | Human | saquinavir | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA | CTD | PMID:16931933 | NUP210 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | NUP210 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NUP210 mRNA | CTD | PMID:22714537 and PMID:38568856 | NUP210 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NUP210 mRNA | CTD | PMID:29301061 and PMID:34032870 | NUP210 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of NUP210 mRNA | CTD | PMID:31758290 | NUP210 | Human | thapsigargin | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Thapsigargin results in decreased expression of NUP210 protein | CTD | PMID:35544339 | NUP210 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of NUP210 mRNA | CTD | PMID:38568856 | NUP210 | Human | titanium dioxide | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of NUP210 mRNA | CTD | PMID:27760801 | NUP210 | Human | titanium dioxide | increases methylation | ISO | Nup210 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of NUP210 gene | CTD | PMID:35295148 | NUP210 | Human | topotecan | multiple interactions | ISO | Nup210 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NUP210 mRNA | CTD | PMID:25729387 | NUP210 | Human | topotecan | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of NUP210 mRNA | CTD | PMID:25729387 | NUP210 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of NUP210 mRNA | CTD | PMID:24935251 and PMID:26272509 | NUP210 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA | CTD | PMID:27188386 | NUP210 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of NUP210 mRNA | CTD | PMID:30510588 | NUP210 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of NUP210 mRNA | CTD | PMID:37042841 | NUP210 | Human | triptonide | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | triptonide results in decreased expression of NUP210 mRNA | CTD | PMID:33045310 | NUP210 | Human | trovafloxacin | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of NUP210 mRNA | CTD | PMID:35537566 | NUP210 | Human | tungsten | decreases expression | ISO | Nup210 (Mus musculus) | 6480464 | Tungsten results in decreased expression of NUP210 mRNA | CTD | PMID:30912803 | NUP210 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of NUP210 mRNA | CTD | PMID:28818685 | NUP210 | Human | valproic acid | decreases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of NUP210 mRNA | CTD | PMID:21318169 | NUP210 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NUP210 mRNA | CTD | PMID:25979313 | NUP210 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NUP210 mRNA | CTD | PMID:23179753 | NUP210 | Human | vinclozolin | increases expression | ISO | Nup210 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of NUP210 mRNA | CTD | PMID:20566332 | NUP210 | Human | zidovudine | multiple interactions | ISO | Nup210 (Mus musculus) | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NUP210 mRNA more ... | CTD | PMID:16931933 | |